logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

Chan-Young Ock

AstraZeneca
H指数:23
被引数:2,112

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Differential implications of tumor endothelial cell and lymphocyte densities in advanced hepatocellular carcinoma patients treated with immunotherapy

肿瘤内皮细胞和淋巴细胞密度在免疫治疗治疗的晚期肝细胞癌患者中的差异意义

npj Precision Oncology
IF8
2025-12-110
OAAI
Gwangil Kim; Beodeul Kang; Jung Yong Hong; Haeyoun Kang; Jung Sun Kim; Sohyun Hwang; Sung Hwan Lee; Sang Hoon Jung; Chansik An; Won Suk Lee; Chiyoon Oum; Gahee Park; Mingu Kang; Yoojoo Lim; Jin Woo Oh; Siraj M. Ali; Chan-Young Ock; Chan Kim; Ho Yeong Lim; Hong Jae Chon
Deep Learning Predicts EGFR Mutation Status from Histology Images in Non-Small Cell Lung Cancer

深度学习从组织学图像预测非小细胞肺癌中EGFR突变状态

Cancer Research Communications
IF0
2025-12-010
OA
Park, Jongchan; Shin, Sangwon; Hwang, Woochan; Keum, Seongho; Brattoli, Biagio; Rawson, Jack H.; Lee, Taebum; Pereira, Sergio; Ahn, Chang Ho; Senior, Michael J. T.; Qaiser, Talha; Kim, Seokhwi; Kim, Hyojin; Chung, Jin-Haeng; Choi, Yoon-La; Lee, Se-Hoon; Bannister, Huw; Riboni-Verri, Elia; Ock, Chan-Young; Hill, Ross J.; Ali, Siraj; Moore, Luiza
Genomic and transcriptomic analyses of residual invasive triple-negative breast cancer after neoadjuvant chemotherapy in the prospective MIRINAE trial (a randomized phase II trial of adjuvant atezolizumab plus capecitabine compared to capecitabine; KCSG-BR18-21)

MIRINAE试验（一项比较辅助阿替利珠单抗联合卡培他滨与单用卡培他滨的随机II期试验；KCSG-BR18-21）中，新辅助化疗后残留浸润性三阴性乳腺癌的基因组学和转录组学分析

ESMO Open
IF8.3
2025-09-240
PREAI
S.-A. Im; K. Park; J. Koh; C. Park; K.H. Jung; J. Lee; H.K. Ahn; A. Lee; S.H. Sim; M.H. Kim; J.H. Kim; J.H. Kim; K.E. Lee; K.H. Park; J. Bae; M.H. Lee; S. Lim; H.J. Kim; D.-W. Lee; J.H. Jeong; K.S. Lee; J. Sohn; K.J. Suh; J.-Y. Kim; Y.J. Cha; J. Moon; C.-Y. Ock; S.-B. Kim; K. Shin; H. Chae; G.M. Kim; K.-H. Lee; W.-Y. Park; Y.H. Park; I.H. Park
OCELOT 2023: Cell detection from cell-tissue interaction challenge

OCELOT 2023：基于细胞-组织相互作用的细胞检测挑战

Medical Image Analysis
IF11.8
2025-08-070
PRE
JaeWoong Shin; Jeongun Ryu; Aaron Valero Puche; Jinhee Lee; Biagio Brattoli; Wonkyung Jung; Soo Ick Cho; Kyunghyun Paeng; Chan-Young Ock; Donggeun Yoo; Zhaoyang Li; Wangkai Li; Huayu Mai; Joshua Millward; Zhen He; Aiden Nibali; Lydia Anette Schoenpflug; Viktor Hendrik Koelzer; Xu Shuoyu; Ji Zheng; Hu Bin; Yu-Wen Lo; Ching-Hui Yang; Sérgio Pereira
First-In-Human Dose Finding Study of Venadaparib (IDX-1197), a Potent and Selective PARP Inhibitor, in Patients With Advanced Solid Tumors

首次人体剂量探索研究：Venadaparib（IDX-1197），一种强效且选择性的PARP抑制剂，在晚期实体瘤患者中的应用

CANCER MEDICINE
IF3.1
2025-02-130
OAAI
Kim, Sung-Bae; Bae, Kyun-Seop; Lee, Jae Lyun; Lee, Won Sik; Ock, Chan-Young; Lee, Myong-Jae; Bang, Jeongsook; Hong, Min Ju; Roh, Eun-Jihn; Ha, Kyoung Soo; Lim, Jong-Ha; Kim, Yong-Man
A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma
CLINICAL CANCER RESEARCH
IF10.2
2024-03-083
PRE
Kim, Chang Gon; Hong, Min Hee; Kim, Dahee; Lee, Brian Hyohyoung; Kim, Hyunwook; Ock, Chan-Young; Kelly, Geoffrey; Bang, Yoon Ji; Kim, Gamin; Lee, Jung Eun; Kim, Chaeyeon; Kim, Se-Heon; Hong, Hyun Jun; Park, Young Min; Sim, Nam Suk; Park, Heejung; Park, Jin Woo; Lee, Chang Geol; Kim, Kyung Hwan; Park, Goeun; Jung, Inkyung; Han, Dawoon; Kim, Jong Hoon; Cha, Junha; Lee, Insuk; Kang, Mingu; Song, Heon; Oum, Chiyoon; Kim, Seulki; Kim, Sukjun; Lim, Yoojoo; Kim-Schulze, Seunghee; Merad, Miriam; Yoon, Sun Och; Kim, Hyun Je; Koh, Yoon Woo; Kim, Hye Ryun

研究方向

暂未获取到该数据
S
Se‐Hoon Lee
H 指数:87论文数:1,134被引数:3.2万
K
Kyunghyun Paeng
H 指数:14论文数:99被引数:1,715
B
Bhumsuk Keam
H 指数:63论文数:697被引数:1.7万
S
Soo Ick Cho
H 指数:22论文数:158被引数:1,794
S
Seokhwi Kim
H 指数:19论文数:87被引数:1,604
G
Gahee Park
H 指数:14论文数:60被引数:562
D
Dae Seog Heo
H 指数:77论文数:662被引数:2.3万
T
Tae Min Kim
H 指数:69论文数:757被引数:2.1万
S
Sérgio Pereira
H 指数:26论文数:92被引数:1.1万
S
Sangjoon Choi
H 指数:17论文数:88被引数:1,295